Troschke-Meurer, S., Siebert, N., Marx, M., Zumpe, M., Ehlert, K., Mutschlechner, O., . . . Lode, H. N. (2019). Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2. Oncoimmunology.

Troschke-Meurer, Sascha, Nikolai Siebert, Madlen Marx, Maxi Zumpe, Karoline Ehlert, Oliver Mutschlechner, Hans Loibner, Ruth Ladenstein, و Holger N. Lode. "Low CD4⁺/CD25⁺/CD127⁻ Regulatory T Cell- and High INF-γ Levels Are Associated With Improved Survival of Neuroblastoma Patients Treated With Long-term Infusion of Ch14.18/CHO Combined With Interleukin-2." Oncoimmunology 2019.

Troschke-Meurer, Sascha, et al. "Low CD4⁺/CD25⁺/CD127⁻ Regulatory T Cell- and High INF-γ Levels Are Associated With Improved Survival of Neuroblastoma Patients Treated With Long-term Infusion of Ch14.18/CHO Combined With Interleukin-2." Oncoimmunology 2019.